Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Stuttgart - Delayed Quote • EUR Blueprint Medicines Corp (2L9.SG) Follow Add holdings 76.18 +1.82 +(2.45%) At close: April 25 at 9:47:01 PM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 2L9.SG 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 2L9.SG View More All News Press Releases SEC Filings Blueprint Medicines to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 Blueprint Medicines (BPMC) Expected to Beat Earnings Estimates: Should You Buy? Blueprint Medicines Corporation (BPMC): Among Takeover Rumors Hedge Funds Are Buying 3 High Growth Tech Stocks In The US Market Adma Biologics (ADMA) Moves 7.8% Higher: Will This Strength Last? Blueprint Medicines to Present at 24th Annual Needham Virtual Healthcare Conference Is Blueprint Medicines (BPMC) One of the Best Mid Cap Biotech Stocks to Buy? Is Blueprint Medicines Corporation (BPMC) a Promising Biotech Stock According to Wall Street Analysts Blueprint Medicines (BPMC): Among Stocks Insiders Are Selling In March Reddit initiated, Netflix upgraded: Wall Street’s top analyst calls Exploring High Growth Tech Stocks In The US Market March 2025